Skip to main content
Top
Published in: Journal of General Internal Medicine 3/2014

01-03-2014 | Capsule Commentary

Capsule Commentary on Tokes et al. Disease and Treatment Perceptions Among Asian Americans Diagnosed with Chronic Hepatitis B Infection

Author: Marij A. Hillen, PhD

Published in: Journal of General Internal Medicine | Issue 3/2014

Login to get access

Excerpt

Chronic hepatitis B disproportionally affects Asian-Americans in the US. Tokes et al.1 studied Asian-Americans with chronic hepatitis B to evaluate their attitudes toward treatment. Using a discrete choice model, they examined how costs and potential side effects influenced patients’ evaluations and decisions to (not) take medication, as well as their relative importance. They found that nearly half were reluctant to start treatment; that most subjects were aware of the potential long-term consequences of chronic hepatitis B, were aware of the treatment options, and worried most about long-term kidney damage due to medication use. Costs were a second important consideration. They also found that Asian-Americans overstated the potential impact of diet and lifestyle in controlling their disease. …
Literature
1.
go back to reference Tokes K, Quadri S, Cahill P, Chiu G, Ivanov A, Tang H. Disease and treatment perceptions among Asian Americans diagnosed with chronic hepatitis B infection. J Gen Intern Med. 2013. doi: 10.1007/s11606-013-2673-0. Tokes K, Quadri S, Cahill P, Chiu G, Ivanov A, Tang H. Disease and treatment perceptions among Asian Americans diagnosed with chronic hepatitis B infection. J Gen Intern Med. 2013. doi:​ 10.​1007/​s11606-013-2673-0.
2.
go back to reference Street RL, Haidet P. How well do doctors know their patients? Factors affecting physician understanding of patients’ health beliefs. Journal of General Internal Medicine. 2011;26:21–7.PubMedCentralPubMedCrossRef Street RL, Haidet P. How well do doctors know their patients? Factors affecting physician understanding of patients’ health beliefs. Journal of General Internal Medicine. 2011;26:21–7.PubMedCentralPubMedCrossRef
3.
go back to reference Elder JP, Ayala GX, Harris S. Theories and intervention approaches to health-behavior change in primary care. American Journal of Preventive Medicine. 1999;17:275–84.PubMedCrossRef Elder JP, Ayala GX, Harris S. Theories and intervention approaches to health-behavior change in primary care. American Journal of Preventive Medicine. 1999;17:275–84.PubMedCrossRef
4.
go back to reference Zolnierek KBH, DiMatteo MR. Physician communication and patient adherence to treatment a meta-analysis. Med Care. 2009;47:826–34.PubMedCrossRef Zolnierek KBH, DiMatteo MR. Physician communication and patient adherence to treatment a meta-analysis. Med Care. 2009;47:826–34.PubMedCrossRef
Metadata
Title
Capsule Commentary on Tokes et al. Disease and Treatment Perceptions Among Asian Americans Diagnosed with Chronic Hepatitis B Infection
Author
Marij A. Hillen, PhD
Publication date
01-03-2014
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 3/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2697-5

Other articles of this Issue 3/2014

Journal of General Internal Medicine 3/2014 Go to the issue

Clinical Practice: Clinical Images

Empyema Necessitatis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine